Literature DB >> 2246506

IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate.

S Murakami1, K Miyake, C H June, P W Kincade, R J Hodes.   

Abstract

Pgp-1 expression was examined in unstimulated B cell populations and in B cells activated with several polyclonal stimuli. Flow cytometry analysis demonstrated that Pgp-1 expression increased when B cells were activated with supernatant of cloned Th2 cells, with LPS, or with IL-5, stimuli that induced polyclonal proliferation and differentiation. IL-5-primed B cells were phenotypically unique and could be divided into two distinct subpopulations based on the brightness of Pgp-1 expression. Furthermore, sterile sorting experiments showed that proliferating and differentiating B cells were highly enriched in a Pgp-1-bright, Ia-dull, B220-dull subpopulation. The possibility that Pgp-1 expressed on activated B cells functions as an adhesion molecule was evaluated by assessing adhesion of activated B cells to defined substrates. It was found that IL-5-activated B cells bound strongly to hyaluronate-coated surface, and this binding was specifically inhibited by anti-Pgp-1 Ab. These findings suggest that Pgp-1 expression is a useful marker which, under defined conditions, identifies the proliferating and differentiating subset of activated B cells. Moreover, the Pgp-1 bright subset of IL-5-primed B cells binds to hyaluronate in a Pgp-1-dependent manner that suggests a potential role of Pgp-1 in the in vivo adherence and trafficking of activated B cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246506

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells.

Authors:  Z Zheng; R D Cummings; P E Pummill; P W Kincade
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

3.  CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.

Authors:  R A Clark; R Alon; T A Springer
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

Review 4.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

5.  CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells.

Authors:  K S Hathcock; H Hirano; R J Hodes
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis.

Authors:  S Katoh; Y Matsubara; H Taniguchi; K Fukushima; H Mukae; J Kadota; S Matsukura; S Kohno
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

7.  Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.

Authors:  P Estess; H C DeGrendele; V Pascual; M H Siegelman
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

8.  Expression of CD44 on rheumatoid synovial fluid lymphocytes.

Authors:  D Kelleher; A Murphy; N Hall; M B Omary; G Kearns; A Long; E B Casey
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

9.  CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.

Authors:  M Kryworuckho; F Diaz-Mitoma; A Kumar
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

10.  Very late antigen integrins are involved in the adhesive interaction of lymphoid cells to human gingival fibroblasts.

Authors:  S Murakami; T Saho; Y Shimabukuro; R Isoda; Y Miki; H Okada
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.